Ownership history in BARCLAYS PLC · 8 quarters on record
This page tracks every 13F SEC filing in which BARCLAYS PLC reported a position in TOURMALINE BIO INC (TRML). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 27,801 | -16,532 | -37.3% | 0.00% | $1.3M | — |
| 2025 Q2 | ADDED | 44,333 | +12,538 | +39.4% | 0.00% | $709K | — |
| 2025 Q1 | REDUCED | 31,795 | -26,771 | -45.7% | 0.00% | $484K | — |
| 2024 Q4 | ADDED | 58,566 | +26,733 | +84.0% | 0.00% | $1.2M | — |
| 2024 Q3 | ADDED | 31,833 | +23,536 | +283.7% | 0.00% | $819K | — |
| 2024 Q2 | ADDED | 8,297 | +5,055 | +155.9% | 0.00% | $107K | — |
| 2024 Q1 | ADDED | 3,242 | +2,538 | +360.5% | 0.00% | $74K | — |
| 2023 Q4 | INITIATED | 704 | — | — | 0.00% | $18K | — |
As of 2025 Q3 — sorted by position size